04/02/2026
Understanding your treatment options can help you feel more confident in your care journey.
In this video, Dr. Gregory Vidal explains what first-line treatment often looks like for patients with ER-positive, HER2-negative metastatic breast cancer. Learn how endocrine therapy and CDK4/6 inhibitors may work together to slow cancer growth, maintain quality of life, and support a personalized treatment plan.
In this segment, Dr. Gregory Vidal outlines what a typical first-line treatment plan looks like for patients with ER-positive, HER2-negative metastatic breast cancer.